Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria
Open Access
- 1 February 2021
- journal article
- research article
- Published by Elsevier in European Urology Oncology
- Vol. 4 (1) , 93-101
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysisEuropean Urology, 2020
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 UpdateEuropean Urology, 2019
- Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder CancerEuropean Urology, 2019
- The Prevalence of Bladder Cancer During Cystoscopy for Asymptomatic Microscopic HematuriaUrology, 2019
- Development of a 90-Minute Integrated Noninvasive Urinary Assay for Bladder Cancer DetectionJournal of Urology, 2018
- Economic Burden of Bladder Cancer Across the European UnionEuropean Urology, 2016
- Epidemiology and Risk Factors of Urothelial Bladder CancerEuropean Urology, 2013
- Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA GuidelineJournal of Urology, 2012
- Patients with microscopic and gross hematuria: practice and referral patterns among primary care physicians in a universal health care systemCanadian Urological Association Journal, 2011
- Carcinoma of the Bladder: A Clinical and Pathological Analysis of 87 Autopsy CasesJournal of Urology, 1981